Table 2 Primary Outcomes Stratified by Patient Sex and Risk
Outcomes | Males | Females | p-value | ||
|---|---|---|---|---|---|
Total Low Risk, No. (%) | N = 101 (18%) | N = 85 (17%) | |||
CTA cardiac | 3 | (3%) | 2 | (2%) | > 0.99 |
Stress Testing | 0 | (0%) | 2 | (2%) | > 0.99 |
Coronary Angiogram | 2 | (2%) | 0 | (0%) | > 0.99 |
PCI | 1 | (1%) | 0 | (0%) | > 0.99 |
CABG | 0 | (0%) | 0 | (0%) | > 0.99 |
Total Intermediate Risk, No. (%) | N = 362 (64%) | N = 340 (67%) | |||
CTA cardiac | 11 | (3%) | 9 | (3%) | 0.75 |
Stress Testing | 22 | (6%) | 22 | (6%) | 0.83 |
Coronary Angiogram | 19 | (5%) | 14 | (4%) | 0.48 |
PCI | 5 | (1%) | 1 | (0.3%) | 0.22 |
CABG | 1 | (0.3%) | 2 | (1%) | 0.61 |
Total High Risk, No. (%) | N = 104 (18%) | N = 86 (17%) | |||
CTA cardiac | 6 | (6%) | 3 | (3%) | 0.52 |
Stress Testing | 18 | (17%) | 11 | (13%) | 0.39 |
Coronary Angiogram | 34 | (33%) | 14 | (16%) | 0.01 |
PCI | 19 | (18%) | 7 | (8%) | 0.04 |
CABG | 5 | (5%) | 1 | (1%) | 0.22 |